Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture-derived H5N1 (aH5n1c) influenza vaccine in adults and older adults

• Main Authors: Sharon S. Frey (Author), Eve Versage (Author), Esther Van Twuijver (Author), Matthew Hohenboken (Author)
• 格式: 图书
• 出版: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

MF59-adjuvanted H5N1, cell culture-derived inactivated influenza vaccine (aH5N1c, AUDENZ®, Seqirus) is available for persons 6 months of age and older. During a pandemic, lack of preexisting immunity to novel influenza strains increases morbidity and mortality. This study examined the potential for...